Arginine Methylation of β-Catenin Induced by PRMT2 Aggravates LPS-Induced Cognitive Dysfunction and Depression-Like Behaviors by Promoting Ferroptosis
- PMID: 38430350
- DOI: 10.1007/s12035-024-04019-5
Arginine Methylation of β-Catenin Induced by PRMT2 Aggravates LPS-Induced Cognitive Dysfunction and Depression-Like Behaviors by Promoting Ferroptosis
Abstract
Depression is a prevalent and debilitating psychiatric disorder, imposing substantial societal and individual burdens. This study aims to investigate the involvement of ferroptosis and microglial polarization in the pathogenesis of depression, as well as the underlying mechanism. Increased protein arginine methyltransferase 2 (PRMT2) expression was observed in BV2 cells and the hippocampus following lipopolysaccharide (LPS) stimulation. Mechanistically, alkylation repair homolog protein 5 (ALKBH5)-mediated m6A modification enhanced the stability of PRMT2 mRNA. PRMT2 promoted arginine methylation of β-catenin and induced proteasomal degradation of β-catenin proteins, resulting in transcriptional inhibition of glutathione peroxidase 4 (GPX4). The upregulation of PRMT2 further accelerated microglia polarization by activating ferroptosis through the β-catenin-GPX4 axis. Depletion of PRMT2 improved LPS-induced depressive- and anxiety-like behaviors as well as cognitive impairment by inhibiting ferroptosis and M1 polarization of microglia. Our findings underscore the crucial involvement of the ALKBH5-PRMT2-β-catenin-GPX4 axis in ferroptosis and M1 polarization of microglia, thereby offering novel insights into the pathogenesis interventions for depression.
Keywords: Depression; Ferroptosis; Microglia polarization; PRMT2; m6A modification.
© 2024. The Author(s), under exclusive licence to Springer Science+Business Media, LLC, part of Springer Nature.
Similar articles
-
LRRK2 regulates ferroptosis through the system Xc-GSH-GPX4 pathway in the neuroinflammatory mechanism of Parkinson's disease.J Cell Physiol. 2024 May;239(5):e31250. doi: 10.1002/jcp.31250. Epub 2024 Mar 13. J Cell Physiol. 2024. PMID: 38477420
-
Nicotinamide mononucleotide mitigates neuroinflammation by enhancing GPX4-mediated ferroptosis defense in microglia.Brain Res. 2024 Dec 15;1845:149197. doi: 10.1016/j.brainres.2024.149197. Epub 2024 Aug 30. Brain Res. 2024. PMID: 39216693
-
Human C15orf39 Inhibits Inflammatory Response via PRMT2 in Human Microglial HMC3 Cell Line.Int J Mol Sci. 2024 May 30;25(11):6025. doi: 10.3390/ijms25116025. Int J Mol Sci. 2024. PMID: 38892217 Free PMC article.
-
Arginine methylation by PRMT2 promotes IFN-β production through TLR4/IRF3 signaling pathway.Mol Immunol. 2021 Nov;139:202-210. doi: 10.1016/j.molimm.2021.08.014. Epub 2021 Sep 25. Mol Immunol. 2021. PMID: 34583098
-
PRMT5-mediated arginine methylation stabilizes GPX4 to suppress ferroptosis in cancer.Nat Cell Biol. 2025 Apr;27(4):641-653. doi: 10.1038/s41556-025-01610-3. Epub 2025 Mar 3. Nat Cell Biol. 2025. PMID: 40033101
Cited by
-
Ferroptosis-associated signaling pathways and therapeutic approaches in depression.Front Neurosci. 2025 Mar 19;19:1559597. doi: 10.3389/fnins.2025.1559597. eCollection 2025. Front Neurosci. 2025. PMID: 40177374 Free PMC article. Review.
-
Ghrelin Induces Ferroptosis Resistance and M2 Polarization of Microglia to Alleviate Neuroinflammation and Cognitive Impairment in Alzheimer's Disease.J Neuroimmune Pharmacol. 2025 Jan 11;20(1):6. doi: 10.1007/s11481-024-10165-3. J Neuroimmune Pharmacol. 2025. PMID: 39797928
-
Iron homeostasis and ferroptosis in human diseases: mechanisms and therapeutic prospects.Signal Transduct Target Ther. 2024 Oct 14;9(1):271. doi: 10.1038/s41392-024-01969-z. Signal Transduct Target Ther. 2024. PMID: 39396974 Free PMC article. Review.
-
Overexpression of ATF4 Inhibits Ferroptosis to Alleviate Anxiety Disorders by Activating the TGF-β Signaling Pathway.Neuropsychiatr Dis Treat. 2024 Oct 16;20:1969-1983. doi: 10.2147/NDT.S480782. eCollection 2024. Neuropsychiatr Dis Treat. 2024. PMID: 39430656 Free PMC article.
-
The role of microglia in neurodegenerative diseases: from the perspective of ferroptosis.Acta Pharmacol Sin. 2025 Apr 30. doi: 10.1038/s41401-025-01560-4. Online ahead of print. Acta Pharmacol Sin. 2025. PMID: 40307457 Review.
References
-
- Marwaha S, Palmer E, Suppes T, Cons E, Young AH, Upthegrove R (2023) Novel and emerging treatments for major depression. Lancet 401(10371):141–153. https://doi.org/10.1016/S0140-6736(22)02080-3 - DOI - PubMed
-
- Wang H, He Y, Sun Z, Ren S, Liu M, Wang G, Yang J (2022) Microglia in depression: an overview of microglia in the pathogenesis and treatment of depression. J Neuroinflammation 19(1):132. https://doi.org/10.1186/s12974-022-02492-0 - DOI - PubMed - PMC
-
- Ho J, Tambyah PA, Paterson DL (2010) Multiresistant Gram-negative infections: a global perspective. Curr Opin Infect Dis 23(6):546–553. https://doi.org/10.1097/QCO.0b013e32833f0d3e - DOI - PubMed
-
- Lasselin J, Schedlowski M, Karshikoff B, Engler H, Lekander M, Konsman JP (2020) Comparison of bacterial lipopolysaccharide-induced sickness behavior in rodents and humans: relevance for symptoms of anxiety and depression. Neurosci Biobehav Rev 115:15–24. https://doi.org/10.1016/j.neubiorev.2020.05.001 - DOI - PubMed
-
- Sabedra Sousa FS, Birmann PT, Bampi SR, Fronza MG, Balaguez R, Alves D, Leite MR, Nogueira CW, Bruning CA, Savegnago L (2019) Lipopolysaccharide-induced depressive-like, anxiogenic-like and hyperalgesic behavior is attenuated by acute administration of alpha-(phenylselanyl) acetophenone in mice. Neuropharmacology 146:128–137. https://doi.org/10.1016/j.neuropharm.2018.11.028 - DOI - PubMed
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical